You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
System for automatic classification of rodent vocalizations
SBC: BIOSPEECH INC Topic: 101DESCRIPTION provided by applicant Depression dementia schizophrenia substance abuse developmental disorders and speech related disabilities can feature impairments in the ability to express emotions Development of treatments for these impairments presents a formidable challenge In this regard several researchers who study rodent models of mental illness have more recently focused upon t ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of Novel S. aureus Antibiotics with Reduced Resistance Susceptibility
SBC: NOVALEX THERAPEUTICS, INC. Topic: NIAIDDESCRIPTION provided by applicant Widespread antibiotic use has accelerated S aureus resistance to almost all marketed antibiotic classes including beta lactams fluoroquinolones macrolides aminoglycosides tetracyclines as well as the newer linezolid and daptomycin Methicillin resistant S aureus MRSA is an increasing public health threat with deaths from MRSA infections already compar ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of broad spectrum Hepatitis C Virus NS3/4A protease inhibitors
SBC: NOVALEX THERAPEUTICS, INC. Topic: NIAIDDESCRIPTION provided by applicant This is a collaborative proposal to develop inhibitors with reduced susceptibility to resistance and improved genotype spectrum of activity against the NS A protease of the Hepatitis C virus HCV Over three percent of the worldandapos s population is infected with the hepatitis C virus HCV Unfortunately the current best treatment is still quite challeng ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of a Novel ELISA Kit for Screening Potential JAK3 Inhibitors
SBC: Twenty First Century Therapeutics, Inc. Topic: 300DESCRIPTION provided by applicant Janus kinase JAK is an intracellular kinase involved in cytokine and antibody receptor signaling it is frequently over activated during the course of inflammatory autoimmune diseases Therefore suitable JAK inhibitors that modulate the overexpression of JAK may be potential agents for treating autoimmune diseases Logically it is of significant import ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Nucleoside Phosphonate Analogs for the Treatment of Adenoviral Infection
SBC: TSRL, INC. Topic: NIAIDDESCRIPTION provided by applicant Adenovirus can be a significant health risk for immune compromised patients both adult and pediatric patients In pediatric patients in particular complications associated with adenoviral infection include pneumonia urinary infections and hepatitis In the military setting adenoviruses are endemic in Department of Defense basic recruit training installation ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of a Reliable, Low-Cost and User-Friendly Spot Test Kit for Leaded Paint and Dust Based on Recent Advances in Bionanotechnology
SBC: ANDALYZE, INC. Topic: 05NCERD9Lead in household paint and dust is a serious health hazard, as low-level lead exposure can result in a number of adverse health effects, especially in children. Onsite and real-time detection and quantification of lead in paint/dust are very important to homeowners and certified lead-based paint removal professionals. Toward this end, both field-portable equipment (such as X-ray fluorescenc ...
SBIR Phase I 2006 Environmental Protection Agency -
Balloon Platforms for Remote Sensing of Water Quality in Mixing Zones
SBC: PHYSICAL SCIENCES INC. Topic: 05NCERD4MixZon, Inc., hypothesizes that lightweight infrared (IR) and video cameras mounted on an unmanned tethered helium balloon accessible via a wireless network can remotely sense water quality at site scales. MixZon will demonstrate the technical feasibility of a ground-based network to monitor and control balloon-mounted, IP-enabled wireless IR and video cameras for measurement of the spatial distri ...
SBIR Phase I 2006 Environmental Protection Agency -
Field Analytical Model for Perchlorate
SBC: IA, Inc. Topic: 05NCERD4Perchlorate is a widely used component of solid fuel, missile and rocket propellants, explosives, and pyrotechnics. It has been shown to reduce iodide uptake into the thyroid gland. The U.S. Environmental Protection Agency (EPA) has found perchlorate contamination in 18 states and believes contamination may exist in as many as 39 states. In early January 2005, the National Academy of Science ...
SBIR Phase I 2006 Environmental Protection Agency -
An Integrated Ecoroof Energy Analysis Model
SBC: Quantec, L.L.C. Topic: 05NCERD5Vegetated roofs (ecoroofs) offer diverse benefits, including energy savings and stormwater runoff reductions. Installation of ecoroofs in both new and existing buildings has expanded significantly during the past 5 years, with several local jurisdictions providing incentives for their installation and the Leadership in Energy and Environmental Design green building rating system offering multiple ...
SBIR Phase I 2006 Environmental Protection Agency -
Silver coatings to combat catheter associated infections
SBC: ACRYMED, INC. Topic: N/ADESCRIPTION (provided by applicant): Abstract Indwelling catheterization is a leading cause of nosocomial infections that present an enormous drain of health care funding in the US. Clinical infections associated with urinary catheterization have been estimated to add more than $1000 to patient care. Those that occur with central venous catheterization escalate the cost to between $35,000 and $50, ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health